These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1802603)

  • 1. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control.
    Alarabi AA; Wikström B; Danielson BG
    Contrib Nephrol; 1991; 93():61-4. PubMed ID: 1802603
    [No Abstract]   [Full Text] [Related]  

  • 2. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
    Merrill RH
    J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood.
    Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E
    Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients.
    Ghezzi PM; Zucchelli P; Ringoir S; Nigrelli S; Santoro A; Gervasio R; Sanz Moreno C; Vanholder R; Botella J
    Adv Exp Med Biol; 1987; 223():267-75. PubMed ID: 3328955
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid metabolism in uremia: effect of regular hemofiltration and hemodialysis treatment.
    Henning HV; Balusek E
    J Dial; 1977; 1(6):595-605. PubMed ID: 608870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness.
    Gibney RT; Stollery DE; Lefebvre RE; Sharun CJ; Chan P
    CMAJ; 1988 Nov; 139(9):861-6. PubMed ID: 3179891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous arteriovenous renal replacement therapy.
    Zobel G; Ring E; Trop M
    Int J Artif Organs; 1987 Jul; 10(4):241-4. PubMed ID: 3666977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
    Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
    Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodialysis and the elderly patient: potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain.
    Avram MR; Pena C; Burrell D; Antignani A; Avram MM
    Am J Kidney Dis; 1990 Oct; 16(4):342-5. PubMed ID: 2220783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic simulation of different modes of renal replacement therapy].
    Iakovleva II; Timokhov VS
    Anesteziol Reanimatol; 2004; (6):16-23. PubMed ID: 15717511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous renal replacement therapy: does technique influence azotemic control?
    Morimatsu H; Uchino S; Bellomo R; Ronco C
    Ren Fail; 2002 Sep; 24(5):645-53. PubMed ID: 12380911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postheparin lipolytic activity in uremic patients treated by hemofiltration.
    Di Giulio S; Lacour B; Man NK; Martinez-Natera F; Faguer P; Drüeke T; Funck-Brentano JL
    Contrib Nephrol; 1982; 29():143-8. PubMed ID: 7075213
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hemodialysis on guanidinopropionic acid metabolism.
    Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
    Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous arteriovenous hemofiltration in the treatment of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects.
    Weiss L; Danielson BG; Wikström B; Hedstrand U; Wahlberg J
    Clin Nephrol; 1989 Apr; 31(4):184-9. PubMed ID: 2496945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak 7c and creatinine weekly clearances in various dialytic procedures.
    Icardi A; Carozzi S; Trasforini D; Moriero E; Lamperi S
    Life Support Syst; 1983; 1 Suppl 1():162-5. PubMed ID: 6336401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.